Skip to main navigation

Work With Us
Contact

Home
About Us
Science
- Publications
Pipeline
UBX1325
Clinical Trials
Investors & Media
Work With Us
Contact
Menu

Press Releases

Corporate Overview
Press Releases
Events & Presentations
Corporate Governance
SEC Filings
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Investor Resources
- Contact IR
- Investor FAQs

Investor Tools

Print Page
Email Page
Contact IR
Email Alerts
RSS Feeds

Year

New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss

February 6, 2024

First page
Previous page
Page 1
Current page 2

Displaying 11 - 11 of 11

©2024 Unity Biotechnology. All Rights Reserved.

Terms & Conditions |
Privacy Policy